Biosearch Technologies Licenses H1N1 Flu IP from CDC | GenomeWeb

NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has licensed H1N1 influenza signatures and the influenza A sub-typing panel signatures from the US Centers for Disease Control and Prevention.

Biosearch, based in Novato, Calif., said it is the first to license the CDC influenza signatures. The license grants Biosearch rights under the CDC patents to manufacture and sell oligonucleotides bearing the H1N1 and influenza A sub-typing signatures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.